Alex Garanto
@jandritu.bsky.social
48 followers
38 following
22 posts
Group leader developing molecular therapies for inherited neurometabolic and retinal diseases at the Radboudumc 👁️🧪🧬
From Barcelona,📍based in Nijmegen
Posts
Media
Videos
Starter Packs
Alex Garanto
@jandritu.bsky.social
· Jul 21
Vacancy - PhD position on Advancing Personalized iPSC-Based Models for Inherited Retinal Diseases
The eye is the window to the world around us. Losing vision either early or late in life is a significant burden for patients. Nowadays, molecular ...
www.radboudumc.nl
Alex Garanto
@jandritu.bsky.social
· Jul 21
Alex Garanto
@jandritu.bsky.social
· Jul 21
Alex Garanto
@jandritu.bsky.social
· Jul 21
Alex Garanto
@jandritu.bsky.social
· Jul 21
Photostimulation Improves Maturation of Human Photoreceptors
The human retina contains photoreceptor cells that detect light and enable vision. The development of these cells involves a tightly regulated cascade of structural and molecular events, and their dys...
www.biorxiv.org
Alex Garanto
@jandritu.bsky.social
· Jul 21
Alex Garanto
@jandritu.bsky.social
· Jul 21
Alex Garanto
@jandritu.bsky.social
· Jul 21
Alex Garanto
@jandritu.bsky.social
· Jul 21
Long-term daily light exposure boosts photoreceptor maturation in retinal organoids
Induced pluripotent stem cell-derived retinal organoids (ROs) have become promising personalized models to study inherited retinal diseases (IRDs) and develop new innovative therapies. Although ROs mi...
www.biorxiv.org
Alex Garanto
@jandritu.bsky.social
· Jul 21
Reposted by Alex Garanto
Reposted by Alex Garanto
Alex Garanto
@jandritu.bsky.social
· Jul 5
Alex Garanto
@jandritu.bsky.social
· Jul 5
Alex Garanto
@jandritu.bsky.social
· Jul 5
Alex Garanto
@jandritu.bsky.social
· Mar 6
12 PhDs on Antisense oligonucleotide research to foster the full therapeutic potential of antisense technology across tissues
EFFecT (European Training Program to Foster the Full Therapeutic Potential of Antisense Technology across Tissues) is a Marie Skłodowska-Curie Doctoral Network (2025-2028), offering 12 PhD positions.
euraxess.ec.europa.eu
Alex Garanto
@jandritu.bsky.social
· Feb 28
Alex Garanto
@jandritu.bsky.social
· Feb 28
12 PhDs on Antisense oligonucleotide research to foster the full therapeutic potential of antisense technology across tissues
EFFecT (European Training Program to Foster the Full Therapeutic Potential of Antisense Technology across Tissues) is a Marie Skłodowska-Curie Doctoral Network (2025-2028), offering 12 PhD positions.
euraxess.ec.europa.eu
Alex Garanto
@jandritu.bsky.social
· Feb 19
Alex Garanto
@jandritu.bsky.social
· Feb 17
12 PhDs on Antisense oligonucleotide research to foster the full therapeutic potential of antisense technology across tissues
EFFecT (European Training Program to Foster the Full Therapeutic Potential of Antisense Technology across Tissues) is a Marie Skłodowska-Curie Doctoral Network (2025-2028), offering 12 PhD positions.
euraxess.ec.europa.eu
Alex Garanto
@jandritu.bsky.social
· Feb 17
Alex Garanto
@jandritu.bsky.social
· Jan 25
Preclinical assessment of splicing modulation therapy for ABCA4 variant c.768G>T in Stargardt disease - Communications Medicine
Karjosukarso et al. investigate antisense oligonucleotides targeting aberrant splicing caused by a recurrent ABCA4 variant in Stargardt disease. A candidate therapeutic molecule that shows a favorable...
www.nature.com